Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...

Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...

NCR to  Morgan Stanley upgrading Suzlon — Here are the top 11 news stories across business, global events, tech, and more ...

This page contains all the questions and answers from the Tower of Tragedy game show section in Banjo-Tooie's Cauldron Keep ...

A set of Goldfish fridge magnets — aka "Holdfish" — to instantly assert the superiority of this cracker to anyone who enters ...